2.100USDMkt Cap: 3.30M USDP/E: —Last update: 2026-05-21
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunother…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap3.30M USD
Enterprise Value-3.78M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-13.39M USD
Revenue/Share—
Last Price2.100 USD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees9
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS00808Y3071
Valuation
P/E (Trailing)—
P/E (Forward)-2.14
PEG—
EV/EBITDA0.54
EV/Revenue—
P/S—
P/B0.30
EPS (TTM)-48.46
EPS (Forward)-0.98
52W Range
2.01090% of range2.110
52W High2.110 USD
52W Low2.010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-261.31%
ROA-181.91%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.65M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-137.93%
Net Debt-6.54M USD
Net Debt/EBITDA0.93
Balance Sheet
Debt/Equity0.13
Current Ratio5.68
Quick Ratio5.53
Book Value/Sh6.898 USD
Cash/Share5.290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 15, 2019
Splits
Last Split1:10
Split DateOct 20, 2025
Analyst Consensus
Rating—
Target (Mean)4.750 USD
Target Range1.500 USD – 8.000 USD
# Analysts2
Ownership
Shares Out.1.57M
Float1.24M
Insiders7.51%
Institutions9.76%
Short Interest
Short Ratio1.1d
Short % Float0.90%
Short % Out.0.90%
Shares Short14.05K
Short (prev mo.)14.05K
Technical
SMA 502.198 (-4.4%)
SMA 2004.706 (-55.4%)
Beta1.50
S&P 52W Chg28.31%
Avg Vol (30d)240.88K
Avg Vol (10d)167.18K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—